Does OLAPARIB Cause Lymphocyte count decreased? 21 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Lymphocyte count decreased have been filed in association with OLAPARIB (Lynparza). This represents 0.1% of all adverse event reports for OLAPARIB.
21
Reports of Lymphocyte count decreased with OLAPARIB
0.1%
of all OLAPARIB reports
4
Deaths
13
Hospitalizations
How Dangerous Is Lymphocyte count decreased From OLAPARIB?
Of the 21 reports, 4 (19.0%) resulted in death, 13 (61.9%) required hospitalization, and 3 (14.3%) were considered life-threatening.
Is Lymphocyte count decreased Listed in the Official Label?
Yes, Lymphocyte count decreased is listed as a known adverse reaction in the official FDA drug label for OLAPARIB.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Lymphocyte count decreased?
FINGOLIMOD (3,232)
DIMETHYL (960)
ALEMTUZUMAB (852)
CLOZAPINE (731)
RITUXIMAB (633)
CYCLOPHOSPHAMIDE (541)
METHYLPREDNISOLONE (532)
CLADRIBINE (448)
DEXAMETHASONE (423)
PREDNISONE (399)
Which OLAPARIB Alternatives Have Lower Lymphocyte count decreased Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL